This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
We are sorry, but there is no personal subscription option available for your country.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Brazil, J. C. et al. Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation. Mucosal Immunol. 15, 211–222 (2022).
Monaghan, T. M. et al. Decreased complexity of serum N-glycan structures associates with successful fecal microbiota transplantation for recurrent Clostridioides difficile infection. Gastroenterology 157, 1676–1678 (2019).
Kao, D. et al. Effect of oral capsule vs colonoscopy-delivered faecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 318, 1985-1993.
Lee, C. H. et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection: a randomized clinical trial. JAMA 315, 142–149 (2016).
Ghani, R. et al. The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases. Gut Microbes 14, 2038856 (2022).
Wortelboer, K. et al. Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine 44, 716–729 (2019).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Monaghan, T.M., Kao, D. & Lauc, G. Some additional considerations on: “Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation”. Mucosal Immunol 15, 525 (2022). https://doi.org/10.1038/s41385-022-00512-z